Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?

To: JMarcus who wrote (385)	2/8/1998 11:55:00 AM
From: Bharat H. Barai	Respond to of 442

I am afraid not. This was a private conference call and not taped by us. I donot believe it was taped by Somatogen either, since they did not mention that they were taping it. We did not hear any bleeps during the conversation either. One point I missed in my last posting was question about Biopure. They stated that it is Bovine Hemoglobin solution and will face lot more scrutiny than Human Hb or genetically engineered Hb. They have not entered Human trials in USA. The vet market in their opinion is so small that Somatogen did not consider it their worthwhile to invest time,energy and resources. My personal opinion as a Hematologist, I doubt patients will ever agree to try bovine Hb in their body, let alone ever accruing enough patients for full clinical trial. When Human Hb solution or genetically engineered Hb is available for trial, who wants to try bovine Hb? I doubt it will ever get to any serious play. I would like to know more about European trials. If Baxter has so much problem with Human Hb solution trials in Europe, how would Biopure get into phase III trials with bovine Hb? Something doesn't add up here. I hope it is not a Netscape type $ 191/share hoopla situation or manipulation with Biopure bovine oxygen therapeutics. I tried to summarize the points as best as I could. You can contact either Peter Mavrelis MD at 219-738-2081 or Somatogen for any additional points. Bharat H. Barai MD